PharmGKB Blog
Wednesday, September 24, 2014

SNP-its Study Summaries

›
The University of Florida Health Personalized Medicine Program has released "SNP-its" study summaries for pharmacogenomic articl...
Thursday, September 18, 2014

CPIC PEG interferon-alpha guideline now available on guideline.gov

›
More CPIC PGx-based dosing guidelines are now available on the National Guideline Clearinghouse (NGC) website.  NGC is a public resource f...
Friday, September 5, 2014

New CPIC Guideline: CYP2C9, HLA-B and Phenytoin

›
Guidelines regarding the use of pharmacogenomic tests for CYP2C9 and HLA-B in dosing phenytoin have been published in Clinical Pharmacology ...
Tuesday, September 2, 2014

PGx of anti-HIV drug described in new PharmGKB pathway

›
Efavirenz (EFV) is a non-nucleoside reverse transcriptase inhibitor used as part of a highly active anti-retroviral therapy (HAART) regimen ...
Friday, August 29, 2014

New study reveals PGx knowledge gaps among physicians

›
A recent study in the journal Pharmacogenomics and Personalized Medicine reveals clear pharmacogenomic “knowledge gaps” among physicians. ...
Friday, August 22, 2014

PGx analysis of 482 whole genomes

›
Few studies have analyzed whole genomes for PGx-related variants - instead, many utilize genotyping platforms made up of known variants. A r...
Tuesday, August 19, 2014

New PharmGKB pathway: Paroxetine

›
The paroxetine PK pathway is the newest addition to PharmGKB's pathway summaries . Paroxetine is a selective serotonin reuptake inhi...
‹
›
Home
View web version

Contributors

  • Caroline Thorn, Curator
  • Katrin Sangkuhl
  • Li Gong
  • Mark Woon
  • Mark Woon
  • Michelle Whirl-Carrillo, Director and Co-PI
  • Ryan Whaley, Technical Lead
  • Teri Klein, Co-PI PharmGKB, CPIC, PharmCAT & ClinGen
Powered by Blogger.